课题基金 / 基金详情

THE ROLE OF NEUTROPHIL AND EOSINOPHIL IN BRONCHIAL ASTHMA.

THE ROLE OF NEUTROPHIL AND EOSINOPHIL IN BRONCHIAL ASTHMA.
中性粒细胞和嗜酸性粒细胞在支气管哮喘中的作用。
批准号:
05670523
负责人:
FUJIMOTO Keisaku
金额:
$1.54万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994

项目摘要

项目成果

FUJIMOTO Keisaku的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this project two studies were performed. First study was to see the effect of specific neutrophil elastase inhibitors, ONO-5046 and FRl34043, on antigen-induced asthmatic responses in allergic dual responded sheep. Ascaris suum inhalation over 20 min induced early (IAR) and late (LAR) bronchoconstriction, airway hyperreactivity to methacholine (AHR), increases in recovered neutrophils and eosinophils and the concentrations of leukotriene B_4 (LTB_4) and thromboxane B_2 (TXB_2) in bronchoalveolar lavage fluid (BALF) during LAR.Continuous infusion of ONO-5046 before antigen challenge signficantly reduced both early and late bronchoconstriction. The inhibitory effect was marked in late bronchoconstriction. Also, the drug significantly reduced the antigen-induced AHR,neutrophil accumulation in the airway and increase in LTB_4 during LAR.Another neutrophil elastase inhibitor, FR134043, also reduced both IAR and LAR.These findings suggest that neutrophil elastase is involved in antigen-induced bronchoconstriction and AHR mediated by neutrophil accumulation and 5-lipoxygenase products in allergic sheep. Second study was to see the effects of specific LTB_4 receptor antagonist, ONO-4057, on asthmatic responses in the same allergic sheep model. The oral administration of the drug before antigen challenge significantly reduced the late phase bronchoconstriction along with the inhibition of eosinophil accumulation in the airway. Also, the drug treatment significantly reduced AHR 8h after antigen challenge. These finding suggest that LTB_4 is an important chemotactic factor for eosinophils and the accumulated eosinophil Plays an important role in the development of LAR and AHR.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
Kubo K,et al.: "Effects of ONO-5046,a specific neutrophil elastase inhibitor, on endotoxin-induces lang injary in sheep." J.Appl.Physiol.77. 1333-1340 (1994)
Kubo K 等人:“ONO-5046(一种特定的中性粒细胞弹性蛋白酶抑制剂)对内毒素诱导的绵羊 lang injary 的影响。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Fujimoto K.,et al.: "Neutrophil elastase inhibitor reduces asthmatic responses in allergic sheep." Respiration Physiology. (in press). (1995)
Fujimoto K.等人:“中性粒细胞弹性蛋白酶抑制剂可减少过敏性绵羊的哮喘反应。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Okubo, Y.et al: "Cytokine production on patients with mite-sensitive bronchial asthma. 19GC08 : Int. Arch. Allergy Immunol." 104s :. 46-48 (1994)
Okubo, Y. 等人:“对螨敏感的支气管哮喘患者产生细胞因子。19GC08:Int. Arch. 过敏免疫学。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yoshimura, K.et al: "Leukotriene B_4 induces lung injury in the rabbit : role of neutrophils and effect of indomethacin." J.Appl.Physiol. 74 :. 2174-2179 (1993)
Yoshimura, K. 等人:“白三烯 B_4 诱导兔子肺损伤:中性粒细胞的作用和吲哚美辛的作用。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
28
    MORPHOLOGICAL CHANGES OF AIRWAY REMODELING AND AIRWAY INFLAMMATION IN BRONCHIAL ASTHMA
    • 批准号:
      12670554
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2000
    • 负责人:
      FUJIMOTO Keisaku
    • 依托单位:
    国内基金
    海外基金
    Mettl3/Syk/MAPK通路调控中性粒细胞胞 外诱捕网 (neutrophil extracellular traps, NETs)的形成对脓毒症急性肺损 伤影响的分子机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2025
    • 负责人:
      罗舒华
    • 依托单位:
    骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
    • 批准号:
      82371799
    • 项目类别:
      面上项目
    • 资助金额:
      47.00万元
    • 批准年份:
      2023
    • 负责人:
      杨程德
    • 依托单位:
    IFITM1+ IL1RAP+ neutrophil通过调控巨噬细胞表型转换驱动ALPPS肝再生的机制研究
    • 批准号:
      82370624
    • 项目类别:
      面上项目
    • 资助金额:
      49万元
    • 批准年份:
      2023
    • 负责人:
      吕涛
    • 依托单位:
    基于Neutrophil-DCs-naive T细胞轴研究“脱敏定喘汤”调体治疗中性粒细胞型过敏性哮喘的机制
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2022
    • 负责人:
      周玉美
    • 依托单位: